{'fraction_non_alphanumeric': 0.016494845360824743, 'fraction_numerical': 0.003092783505154639, 'mean_word_length': 5.696551724137931, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
Hazards of Treating Osteoporosis and Hypertension Concurrently with Calcium, Vitamin D, and Distal Diuretics

An adverse drug interaction may result from as many as 8 percent of all prescriptions written.’ The elderly population, in which there is an increase in all types of illnesses, may be at greater risk for adverse drug interactions than the population as a whole, as common conditions of aging are more frequently recognized and treated. In postmenopausal women, the treatment for two commonly occurring conditions-osteoporosis and hypertension-can have a synergistic effect resulting in severe hypercalcemia. Earlier investigators have described the association between thiazide diuretics and hypercalcemia. 2-6 Calcium andl or vitamin D supplementation can potentiate and exacerbate the hypercalcemic effects of distal diuretics. The presented case illustrates the difficulties and dangers of concurrently treating hypertension and osteoporosis in the elderly.